RELNATE DHA (Burel Pharmaceuticals, LLC)
Welcome to the PulseAid listing for the RELNATE DHA drug offered from Burel Pharmaceuticals, LLC. This Fatty Acids, Omega-3 [Chemical/Ingredient],Omega-3 Fatty Acid [EPC],Vitamin B6 Analog [EPC],Vitamin B 6 [Chemical/Ingredient],Analogs/Derivatives [Chemical/Ingredient],Vitamin B 12 [Chemical/Ingredient],Vitamin B12 [EPC],Vitamin D [Chemical/Ingredient],Vitamin D [EPC],Osmotic Laxative [EPC],Increased Large Intestinal Motility [PE],Inhibition Large Intestine Fluid/Electrolyte Absorption [PE],Osmotic Activity [MoA] pharmaceutical is classified as a HUMAN PRESCRIPTION DRUG. Below, you can view details for this drug, such as its dosage form, route of delivery, start market/end market dates, and more. We have also randomly listed additional pharmaceuticals used in the same HUMAN PRESCRIPTION DRUG drug type category.
| LABELER NAME / MANUFACTURER: | Burel Pharmaceuticals, LLC |
| NON-PROPRIETARY NAME: | OMEGA-3 FATTY ACIDS, THIAMINE MONONITRATE, RIBOFLAVIN, PYRIDOXINE HYDROCHLORIDE, CYANOCOBALAMIN, FOLIC ACID, CHOLECALCIFEROL, ASCORBIC ACID, ALPHA-TOCOPHEROL, CUPRIC SULFATE ANHYDROUS, ZINC OXIDE, IRO |
| SUBSTANCE NAME: | OMEGA-3 FATTY ACIDS; THIAMINE MONONITRATE; RIBOFLAVIN; PYRIDOXINE HYDROCHLORIDE; CYANOCOBALAMIN; FOLIC ACID; CHOLECALCIFEROL; ASCORBIC ACID; ALPHA-TOCOPHEROL; CUPRIC SULFATE ANHYDROUS; ZINC OXIDE; IRO |
| TYPE: | HUMAN PRESCRIPTION DRUG |
| PHARMA CLASS: | Fatty Acids, Omega-3 [Chemical/Ingredient],Omega-3 Fatty Acid [EPC],Vitamin B6 Analog [EPC],Vitamin B 6 [Chemical/Ingredient],Analogs/Derivatives [Chemical/Ingredient],Vitamin B 12 [Chemical/Ingredient],Vitamin B12 [EPC],Vitamin D [Chemical/Ingredient],Vitamin D [EPC],Osmotic Laxative [EPC],Increased Large Intestinal Motility [PE],Inhibition Large Intestine Fluid/Electrolyte Absorption [PE],Osmotic Activity [MoA] |
| ROUTE: | ORAL |
| DOSAGE FORM: | CAPSULE, LIQUID FILLED |
| MARKETING CATEGORY NAME: | UNAPPROVED DRUG OTHER |
| START MARKETING DATE: | 2011-05-15 |
| END MARKETING DATE: | 0000-00-00 |
RELNATE DHA HUMAN PRESCRIPTION DRUG Details:
| Item Description | RELNATE DHA from Burel Pharmaceuticals, LLC |
| LABELER NAME: | Burel Pharmaceuticals, LLC |
| DEA SCHEDULE: |
|
| ACTIVE STRENGTH: | 200; 3; 3; 20; 15; 1; 400; 100; 30; 1; 20; 28; 30(mg/1; mg/1; mg/1; mg/1; ug/1; mg/1; [iU]/1; mg/1; [iU]/1; mg/1; mg/1; mg/1; mg/1) |
| START MARKETING DATE: | 2011-05-15 |
| END MARKETING DATE: | 0000-00-00 |
| PRODUCT ID: | 35573-103_28ccc65c-7e07-4315-ae4f-d46bec774366 |
| PRODUCT NDC: | 35573-103 |
| APPLICATION NUMBER: | |
Other OMEGA-3 FATTY ACIDS; THIAMINE MONONITRATE; RIBOFLAVIN; PYRIDOXINE HYDROCHLORIDE; CYANOCOBALAMIN; FOLIC ACID; CHOLECALCIFEROL; ASCORBIC ACID; ALPHA-TOCOPHEROL; CUPRIC SULFATE ANHYDROUS; ZINC OXIDE; IRO Pharmaceutical Manufacturers / Labelers:
